Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 301–400 of 1,000
Mannucci, A., & Goel, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02174-w · Cited by 82
Dielectrophoretic isolation of DNA and nanoparticles from blood
Sonnenberg, A., Marciniak, J. Y., Krishnan, R., & Heller, M. J. (2012) · Electrophoresis · doi:10.1002/elps.201100700 · Cited by 76
Lo, Y. M. D., & Chiu, R. W. K. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.100016 · Cited by 80
Comparison of 4 commercial kits for the extraction of circulating DNA from plasma
Warton, K., Graham, L.-J. K., Yuwono, N. L., & Samimi, G. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.02.004 · Cited by 75
Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Yörüker, E. E., Holdenrieder, S., & Deligezer, U. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.01.016 · Cited by 76
Ronvaux, L., Riva, M., Coosemans, A., Herzog, M., Rommelaere, G., Donis, N., D'Hondt, L. A., & Douxfils, J. (2022) · Cancers · doi:10.3390/cancers14143394 · Cited by 78
Digital PCR: a powerful new tool for noninvasive prenatal diagnosis?
Zimmermann, B. G., Grill, S., Holzgreve, W., Zhong, X. Y., Jackson, L. G., & Hahn, S. (2008) · Prenatal Diagnosis · doi:10.1002/pd.2150 · Cited by 70
Non‐invasive detection of genome‐wide somatic copy number alterations by liquid biopsies
Heitzer, E., Ulz, P., Geigl, J. B., & Speicher, M. R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.004 · Cited by 79
Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
Tan, C. R. C., Zhou, L., & El‐Deiry, W. S. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0320-y · Cited by 83
Arnedos, M., Soria, J., André, F., & Tursz, T. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.07.002 · Cited by 76
Haselmann, V., Ahmad‐Nejad, P., Geilenkeuser, W. J., Duda, A., Gabor, M., Eichner, R., Patton, S. J., & Neumaier, M. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0283 · Cited by 73
Kodahl, A. R., Ehmsen, S., Pallisgaard, N., Jylling, A. M. B., Jensen, J. D., Lænkholm, A., Knoop, A. S., & Ditzel, H. J. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12305 · Cited by 81
Guo, Z., Yang, F., Zhang, J., Zhang, Z., Li, K., Tian, Q., Hou, H., Xu, C., Lu, Q., Ren, Z., et al. (2019) · Advanced Science · doi:10.1002/advs.201901819 · Cited by 79
Next-Generation Liquid Biopsies: Embracing Data Science in Oncology
Im, Y. R., Tsui, D. W. Y., Diaz, L. A., & Wan, J. C. M. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.11.001 · Cited by 70
Self-citationZitt, M., Müller, H. M., Rochel, M., Schwendinger, V., Zitt, M., Goebel, G., DeVries, A., Margreiter, R., Oberwalder, M., Zeillinger, R., et al. (2008) · Disease Markers · doi:10.1155/2008/598071 · Cited by 74
Imamura, T., Komatsu, S., Ichikawa, D., Kawaguchi, T., Miyamae, M., Okajima, W., Ohashi, T., Arita, T., Konishi, H., Shiozaki, A., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i25.5627 · Cited by 79
Wang, R., Li, X., Zhang, H., Wang, K., & He, J. (2017) · Oncotarget · doi:10.18632/oncotarget.20608 · Cited by 68
Liquid Biopsy: From Basic Research to Clinical Practice
Macías, M., Alegre, E., Díaz‐Lagares, Á., Patiño‐García, A., Perez‐Gracia, J. L., Sanmamed, M. F., López‐López, R., Varo, N., & González, Á. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.10.003 · Cited by 80
Goel, G. (2018) · Cancer Management and Research · doi:10.2147/cmar.s88825 · Cited by 69
Carpinetti, P. A., Donnard, E. R., Bettoni, F., Asprino, P. F., Koyama, F. C., Rozanski, A., Sabbaga, J., Habr‐Gama, A., Parmigiani, R. B., Galante, P. A. F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5256 · Cited by 75
A suite of DNA methylation markers that can detect most common human cancers
Vrba, L., & Futscher, B. W. (2017) · Epigenetics · doi:10.1080/15592294.2017.1412907 · Cited by 72
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Vanni, I., Tanda, E. T., Spagnolo, F., Andreotti, V., Bruno, W., & Ghiorzo, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00113 · Cited by 72
Kuo, Y., Chen, J., Fan, C., Li, Y.-S., & Chan, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.024 · Cited by 73
A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer
Wu, X., Zhang, Y., Hu, T., He, X., Zou, Y., Deng, Q., Ke, J., Lian, L., He, X., Zhao, D., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12942 · Cited by 74
Clinical correlates of circulating cell-free DNA tumor fraction
Bredno, J., Lipson, J. A., Venn, O., Aravanis, A. M., & Jamshidi, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256436 · Cited by 74
Rose, K. M., Huelster, H. L., Meeks, J. J., Faltas, B. M., Sonpavde, G., Lerner, S. P., Ross, J. S., Spiess, P. E., Grass, G. D., Jain, R., et al. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00725-2 · Cited by 74
Traver, S., Assou, S., Scalici, E., Haouzi, D., Al-Edani, T., Belloc, S., & Hamamah, S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu031 · Cited by 73
Bordi, P., Re, M. D., Danesi, R., & Tiseo, M. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.08.09 · Cited by 79
Liquid Biopsy in Non-Small Cell Lung Cancer
Molina‐Vila, M. Á., Mayo‐de‐las‐Casas, C., Giménez-Capitán, A. A., Jordana‐Ariza, N., Garzón, M., Balada‐Bel, A., Villatoro, S., Teixidó, C., García‐Peláez, B., Aguado, C., et al. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00069 · Cited by 71
Recent advances in liquid biopsy technologies for cancer biomarker detection
Soda, N., Clack, K., & Shiddiky, M. J. A. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00010e · Cited by 71
Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
Catarino, R., Coelho, A., Araújo, A., Gomes, M. P., Nogueira, A., Lopes, C., & Medeiros, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038559 · Cited by 70
Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids
Tsujiura, M., Ichikawa, D., Konishi, H., Komatsu, S., Shiozaki, A., & Otsuji, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3265 · Cited by 68
Schwarzenbach, H., Eichelser, C., Kropidlowski, J., Janni, W., Rack, B. K., & Pantel, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0142 · Cited by 67
Haselmann, V., Gebhardt, C., Brechtel, I., Duda, A., Czerwinski, C., Sucker, A., Holland‐Letz, T., Utikal, J. S., Schadendorf, D., & Neumaier, M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.281543 · Cited by 72
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
Kulasinghe, A., Wu, H., Punyadeera, C., & Warkiani, M. E. (2018) · Micromachines · doi:10.3390/mi9080397 · Cited by 71
Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery
Brancaccio, M., Natale, F., Falco, G., & Angrisano, T. (2019) · Genes · doi:10.3390/genes11010014 · Cited by 74
Kukita, Y., Uchida, J., Oba, S., Nishino, K., Kumagai, T., Taniguchi, K., Okuyama, T., Imamura, F., & Kato, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081468 · Cited by 64
Lim, S. H.-S., Becker, T. M., Chua, W., Caixeiro, N., Ng, W. L., Kienzle, N., Tognela, A., Lumba, S., Rasko, J. E. J., SOUZA, P. D., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.019 · Cited by 70
The “Liquid Biopsy”: the Role of Circulating DNA and RNA in Central Nervous System Tumors
Connolly, I. D., Li, Y., Gephart, M. H., & Nagpal, S. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0629-6 · Cited by 65
The Translational Status of Cancer Liquid Biopsies
Bratulić, S., Gatto, F., & Nielsen, J. (2019) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-019-00141-2 · Cited by 70
Sonnenberg, A., Marciniak, J. Y., Skowronski, E. A., Manouchehri, S., Rassenti, L. Z., Ghia, E. M., Widhopf, G. F., Kipps, T. J., & Heller, M. J. (2014) · Electrophoresis · doi:10.1002/elps.201400016 · Cited by 73
Prognostic role of PIK 3 CA mutations of cell‐free DNA in early‐stage triple negative breast cancer
Takeshita, T., Yamamoto, Y., Yamamoto‐Ibusuki, M., Inao, T., Sueta, A., Fujiwara, S., Omoto, Y., & Iwase, H. (2015) · Cancer Science · doi:10.1111/cas.12813 · Cited by 67
Colorectal Cancer Blood-Based Biomarkers
Hauptman, N., & Glavač, D. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/2195361 · Cited by 73
Fe–Au Nanoparticle‐Coupling for Ultrasensitive Detections of Circulating Tumor DNA
Hu, P., Zhang, S., Wu, T. S., Ni, D., Fan, W., Zhu, Y. Q., Qian, R., & Shi, J. (2018) · Advanced Materials · doi:10.1002/adma.201801690 · Cited by 64
High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer
Ashley, C. W., Selenica, P., Patel, J., Wu, M. K. Y., Ninčević, J., Lakhman, Y., Zhou, Q. C., Shah, R. H., Berger, M. F., Paula, A. D. C., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1134 · Cited by 74
Addressing the challenges of applying precision oncology
Shin, S. H., Bode, A. M., & Dong, Z. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0032-z · Cited by 62
Sherwood, K. R., & Weimer, E. T. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.09.011 · Cited by 67
Economopoulou, P., Kotsantis, I., Kyrodimos, E., Lianidou, E. S., & Psyrri, A. K. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.09.012 · Cited by 71
Liquid biopsies for management of pancreatic cancer
Samandari, M., Juliá, M. G., Rice, A. J., Chronopoulos, A., & Hernández, A. E. D. R. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.008 · Cited by 70
Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic Opportunities
Lauschke, V. M., Barragán, I., & Ingelman‐Sundberg, M. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053021 · Cited by 69
Garcia, J., Forestier, J., Dusserre, E., Wozny, A., Geiguer, F., Merle, P., Tissot, C., Ferraro‐Peyret, C., Jones, F. S., Edelstein, D. L., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24950 · Cited by 70
Liquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 68
Progress toward liquid biopsies in pediatric solid tumors
Weiser, D. A., West-Szymanski, D. C., Fraint, E., Weiner, S., Rivas, M. A., Zhao, C. W. T., He, C., & Applebaum, M. A. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09825-1 · Cited by 60
The translational potential of circulating tumour DNA in oncology
Patel, K., & Tsui, D. W. Y. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.04.005 · Cited by 67
Azad, T. D., Jin, M. C., Bernhardt, L. J., & Bettegowda, C. (2020) · Neurosurgical FOCUS · doi:10.3171/2019.9.focus19699 · Cited by 70
Circulating free tumor DNA and colorectal cancer
Lecomte, T., Cézé, N., Dorval, E. D., & Laurent‐Puig, P. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.04.015 · Cited by 61
Arbeithuber, B., Makova, K. D., & Tiemann‐Boege, I. (2016) · DNA Research · doi:10.1093/dnares/dsw038 · Cited by 59
Ng, S. B., Chua, C., Ng, M., Gan, A., Poon, P. S., Teo, M., Fu, C., Leow, W. Q., Lim, K. H., Chung, A., et al. (2017) · Scientific Reports · doi:10.1038/srep40737 · Cited by 59
Winther‐Larsen, A., Demuth, C., Fledelius, J., Madsen, A. T., Hjorthaug, K., Meldgaard, P., & Sørensen, B. S. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.215 · Cited by 67
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Vietsch, E. E., Graham, G. T., McCutcheon, J. N., Javaid, A., Giaccone, G., Marshall, J. L., & Wellstein, A. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.08.006 · Cited by 63
Martini, G., Ciardiello, D., Vitiello, P. P., Napolitano, S., Cardone, C., Cuomo, A., Troiani, T., Ciardiello, F., & Martinelli, E. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102023 · Cited by 58
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
Wan, J. C. M., Sasieni, P. D., & Rosenfeld, N. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01033-x · Cited by 82
Assessment of DNA Integrity, Applications for Cancer Research
Zonta, E., Nizard, P., & Taly, V. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.03.002 · Cited by 69
Riediger, A. L., Dietz, S., Schirmer, U. B., Meister, M. A., Heinzmann-Groth, I., Schneider, M. A., Muley, T., Thomas, M., & Sültmann, H. (2016) · Scientific Reports · doi:10.1038/srep33505 · Cited by 64
Characterization of background noise in capture-based targeted sequencing data
Park, G., Park, J. K., Shin, S., Jeon, H.-J., Kim, N. K. D., Kim, Y. J., Shin, H., Lee, E., Lee, K. H., Son, D., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1275-2 · Cited by 63
Tumor DNA: an emerging biomarker in head and neck cancer
Bellairs, J. A., Hasina, R., & Agrawal, N. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9685-x · Cited by 63
Salivary Exosome and Cell-Free DNA for Cancer Detection
Hyun, K.-A., Gwak, H., Lee, J., Kwak, B., & Jung, H. (2018) · Micromachines · doi:10.3390/mi9070340 · Cited by 58
Sierra, J., Marrugo-Ramírez, J., Rodriguez-Trujíllo, R., Mir, M., & Samitier, J. (2020) · Sensors · doi:10.3390/s20051317 · Cited by 64
Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis
Medipally, D., Cullen, D., Untereiner, V., Sockalingum, G. D., Maguire, A., Nguyen, T. N. Q., Bryant, J., Noone, E., Bradshaw, S., Finn, M. A., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920918499 · Cited by 61
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)
Ge, Q., Zhang, Z., Li, S.-N., Ma, J., & Zhao, Z. (2024) · Oncology Letters · doi:10.3892/ol.2024.14681 · Cited by 72
COLD-PCR: improving the sensitivity of molecular diagnostics assays
Milbury, C. A., Li, J., Liu, P., & Makrigiorgos, G. M. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.115 · Cited by 65
Free DNA – new potential analyte in clinical laboratory diagnostics?
Wagner, J. (2012) · Biochemia Medica · doi:10.11613/bm.2012.004 · Cited by 62
Circulating nucleic acids in cancer and pregnancy
Pinzani, P., Salvianti, F., Pazzagli, M., & Orlando, C. (2010) · Methods · doi:10.1016/j.ymeth.2010.02.004 · Cited by 60
Rapid Electrokinetic Isolation of Cancer-Related Circulating Cell-Free DNA Directly from Blood
Sonnenberg, A., Marciniak, J. Y., Rassenti, L. Z., Ghia, E. M., Skowronski, E. A., Manouchehri, S., McCanna, J. P., Widhopf, G. F., Kipps, T. J., & Heller, M. J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.214874 · Cited by 66
Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
Chan, K. C. A. (2014) · 癌症:英文版 · doi:10.5732/cjc.014.10192 · Cited by 57
Symonds, E. L., Pedersen, S. K., Murray, D. H., Jedi, M., Byrne, S. E., Rabbitt, P., Baker, R. T., Bastin, D., & Young, G. P. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0500-5 · Cited by 65
Bamodu, O. A., Chung, C., & Pisanic, T. R. (2023) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2023.100126 · Cited by 69
Keeley, B. P., Stark, A., Pisanic, T. R., Kwak, R., Zhang, Y., Wrangle, J. M., Baylin, S. B., Herman, J. G., Ahuja, N., Brock, M. V., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.023 · Cited by 58
Epigenetic markers of prostate cancer in plasma circulating DNA
Cortese, R., Kwan, A., Lalonde, E., Bryzgunova, O. E., Bondar, A. A., Wu, Y., Gordevičius, J., Park, M., Oh, G., Kaminsky, Z. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds192 · Cited by 61
Polívka, J., Pešta, M., & Jankú, F. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1110021 · Cited by 58
Lin, D., Wu, Q., Qiu, S., Chen, G., Feng, S., Chen, R., & Zeng, H. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102100 · Cited by 56
Danese, E., Minicozzi, A. M., Benati, M., Montagnana, M., Paviati, E., Salvagno, G. L., Gusella, M., Pasini, F., Guidi, G. C., & Lippi, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.351 · Cited by 57
New strategy for the gene mutation identification using surface enhanced Raman spectroscopy (SERS)
Kowalczyk, A., Krajczewski, J., Kowalik, A., Weyher, J. L., Dzięcielewski, I., Chłopek, M., Góźdź, S. S., Nowicka, A. M., & Kudelski, A. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.03.019 · Cited by 55
Arko‐Boham, B., Aryee, N. A., Blay, R. M., Owusu, E. D. A., Tagoe, E. A., Shackie, E.-S. D., Debrah, A. B., & Adu-Aryee, N. A. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.04.062 · Cited by 59
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer
Wang, H., Yang, S., Chen, L., Li, Y., He, P., Wang, G., Dong, H., Ma, P., & Ding, G. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.004 · Cited by 71
Ding, L., Cao, S., Qu, C., Wu, Y., & Yu, S. (2024) · ACS Sensors · doi:10.1021/acssensors.3c02571 · Cited by 55
Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE
Song, J., Cho, M. H., Cho, H., Song, Y., Lee, S.-W., Nam, H. C., Yoon, T.-H., Shin, J. C., Hong, J., Kim, Y., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02426-6 · Cited by 65
Metz, C. H. D., Scheulen, M. E., Bornfeld, N., Lohmann, D. R., & Zeschnigk, M. (2013) · Cancer Medicine · doi:10.1002/cam4.61 · Cited by 60
Chung, J., Son, D., Jeon, H.-J., Kim, K., Park, G., Ryu, G. H., Park, W., & Park, D. (2016) · Scientific Reports · doi:10.1038/srep26732 · Cited by 60
Parsons, H. A., Beaver, J. A., Cimino‐Mathews, A., Ali, S. M., Axilbund, J. E., Chu, D. T. W., Connolly, R. M., Cochran, R. L., Croessmann, S., Clark, T. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1543 · Cited by 58
The development of a liquid biopsy for head and neck cancers
Schmidt, H., Kulasinghe, A., Kenny, L., & Punyadeera, C. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.07.014 · Cited by 54
MAGERI: Computational pipeline for molecular-barcoded targeted resequencing
Shugay, M., Zaretsky, A. R., Shagin, D. A., Shagina, I. A., Volchenkov, I. A., Shelenkov, A. A., Lebedin, M. Y., Bagaev, D. V., Lukyanov, S., & Chudakov, D. M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005480 · Cited by 65
Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers
Maia, M. C., Salgia, M. M., & Pal, S. K. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0297-9 · Cited by 64
Bittla, P., Kaur, S., Sojitra, V., Zahra, A., Hutchinson, J., Folawemi, O., & Khan, S. (2023) · Cureus · doi:10.7759/cureus.45784 · Cited by 78
Digital quantification of mutant DNA in cancer patients
Diehl, F., & Diaz, L. A. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a8e7 · Cited by 53
Self-citationPrognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
Lefébure, B., Charbonnier, F., Fiore, F. D., Tuech, J., Pessot, F. L., Michot, F., Michel, P., & Frébourg, T. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c35c87 · Cited by 53
Biological and chemical sensors for cancer diagnosis
Simon, E. (2010) · Measurement Science and Technology · doi:10.1088/0957-0233/21/11/112002 · Cited by 59
Markou, A. N., Tzanikou, E., Ladas, I., Makrigiorgos, G. M., & Lianidou, E. S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03325 · Cited by 53
Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes
Pös, Z., Pös, O., Styk, J., Mocova, A., Striešková, L., Budiš, J., Kádaši, Ľ., Radvánszky, J., & Szemes, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228634 · Cited by 56
Jacob, S. L., Davis, A. A., Gerratana, L., Velimirovic, M., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1566 · Cited by 58
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.